Schedule 13D ownership disclosure

REGENERON PHARMACEUTICALS COM

Security class unavailable · CUSIP: 75886F107

Event date: 2014-10-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
22,535,558
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000909518-14-000295
Form type
SC 13D/A
Filer
REGENERON PHARMACEUTICALS, INC.
CIK
CIK 872589
Filed
Oct 17, 2014
Reporting period
Oct 15, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub